10-Q: National Vision Soars: Q3 Profit Rebounds, Sales Up 7.9%

National Vision Holdings, Inc. reported a significant return to profitability in Q3 2025 with net income of $3.4 million, driven by strong 7.9% revenue growth and robust comparable store sales.

Summary

• Total net revenue for the three months ended September 27, 2025, increased by $35.8 million, or 7.9%, to $487.3 million, compared to $451.5 million in the prior year.
• Net income for the three months ended September 27, 2025, was $3.372 million, a significant improvement from a net loss of $(8.468) million in the same period last year.
• Diluted earnings per share (EPS) from continuing operations improved to $0.04 for the three months ended September 27, 2025, from a loss of $(0.11) in the prior year.
• Adjusted Comparable Store Sales Growth from continuing operations was 7.7% for the three months ended September 27, 2025, compared to 0.9% in the prior year, reflecting a higher average ticket and strength in managed care.
• For the nine months ended September 27, 2025, total net revenue increased by $98.0 million, or 7.1%, to $1,484.1 million.
• Net income for the nine months ended September 27, 2025, was $26.283 million, up from $0.092 million in the prior year.
• Diluted EPS from continuing operations for the nine months ended September 27, 2025, was $0.33, compared to $0.03 in the prior year.
• The company opened 4 Americas Best stores and closed 2 Fred Meyer stores during the three months ended September 27, 2025, bringing the total store count to 1,242.
• Costs applicable to revenue as a percentage of net revenue decreased to 41.7% for the three months ended September 27, 2025, from 42.1% in the prior year, driven by eyeglass mix and margin improvement.
• No asset impairment charges were recognized during the three months ended September 27, 2025, a significant reduction from $13.7 million in the prior year period.
• The company fully repaid the $84.8 million outstanding principal balance of its 2.50% convertible senior notes due May 15, 2025 (2025 Notes) during the nine months ended September 27, 2025.
• A post-mediation agreement was reached on October 3, 2025, to pay $1.8 million (net of insurance) to settle an Alabama medical negligence lawsuit.
• A California wage and hour class action lawsuit was settled for a gross fund of $4.6 million, with final approval granted on July 29, 2025, and payment made on October 10, 2025.

Sentiment

Score: 8

Explanation: The company demonstrated a strong financial turnaround, moving from a net loss to significant net income. Revenue growth and comparable store sales were robust, indicating healthy operational performance. Cost management improved, and asset impairment charges were substantially reduced. While cash on hand decreased, overall liquidity remains strong with available credit, and debt obligations were reduced through repayment. Legal proceedings are being managed, with some significant cases resolved. The outlook for continued growth and strategic initiatives is positive.

Positives

• Significant turnaround from a net loss of $(8.468) million to a net income of $3.372 million for the three months ended September 27, 2025.
• Strong total net revenue growth of 7.9% for the quarter and 7.1% for the nine months ended September 27, 2025.
• Robust Adjusted Comparable Store Sales Growth of 7.7% for the quarter, indicating healthy underlying business performance.
• Improved diluted EPS from continuing operations to $0.04 for the quarter and $0.33 for the nine months, compared to losses/minimal gains in the prior year.
• Costs applicable to revenue as a percentage of net revenue decreased by 40 basis points for the quarter, reflecting successful pricing and product mix initiatives.
• Absence of asset impairment charges in Q3 2025, compared to $13.7 million in the prior year, indicating improved asset performance and valuation.
• Adjusted Operating Income from continuing operations increased by 38.5% to $19.8 million for the quarter.
• Adjusted EBITDA from continuing operations increased by 14.2% to $41.8 million for the quarter.
• Net cash provided by operating activities increased by $29.8 million to $133.1 million for the nine months ended September 27, 2025.
• Successful full repayment of the $84.8 million 2025 Convertible Senior Notes, reducing debt obligations.
• The Securities Class Action complaint was dismissed with prejudice, and a motion for reconsideration was denied, resolving a significant legal overhang.
• Anticipated full cash repayment of the $3.3 million investment in an AI-powered retinal imaging entity following its acquisition by a co-preferred investor, with no expected gain or loss.

Negatives

• Cash and cash equivalents decreased to $56.030 million as of September 27, 2025, from $73.948 million as of December 28, 2024.
• The company recognized $0.8 million and $2.9 million in severance benefits for certain associates during the three and nine months ended September 27, 2025, respectively, related to organizational restructuring.
• Fred Meyer store count decreased by 11 net closures during the nine months ended September 27, 2025, with two closures due to the host partner ceasing operations.
• Costs of services and plans as a percentage of net sales of services and plans increased from 91.0% to 92.7% for the nine months ended September 27, 2025, primarily due to lower growth in eye exam margin and add-ons revenue.
• Interest expense, net, remained flat for the quarter despite lower debt, primarily due to lower interest income on cash balances.

Risks

• Market volatility, an overall decline in the health of the economy, global macroeconomic conditions, and other factors that may affect consumer spending or behavior.
• Ability to successfully implement transformation initiatives or anticipate the impact of important strategic initiatives.
• Ability to recruit and retain vision care professionals for in-store roles or to provide remote care offerings, with increasing costs and potential constraints in exam capacity.
• Highly competitive optical retail industry.
• Changes in the cost of inputs, such as wage rate increases, inflation, cost increases, and increases in the price of raw materials and energy prices.
• Significant capital requirements to fund expanding business, including updating Enterprise Resource Planning (ERP) and Customer Relationship Management (CRM), and other technological systems and capabilities.
• Potential for growth strategy to strain existing resources and cause the performance of existing stores to suffer.
• Risks associated with leasing substantial amounts of space, including future increases in occupancy costs.
• Potential for certain technological advances, greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, or future drug development for the correction of vision-related problems to reduce the demand for products.
• Ability to successfully manage inventory balances and inventory shrinkage.
• Potential for the loss of, or disruption in the operations of, one or more distribution centers or optical laboratories.
• Performance of Host brands and ability to maintain or extend operating relationships with Host partners, including impacts from the termination of the partnership with Walmart.
• Impact of any significant failure, inadequacy, interruption, or security breach affecting information technology systems, or those of vendors.
• Reliance on third-party coverage and reimbursement, including government programs, for an increasing portion of revenues.
• Ability to comply with state, local, and federal vision care and healthcare laws and regulations, as well as managed vision care laws and regulations.
• Liability stemming from rapidly changing and increasingly stringent laws, regulations, contractual obligations, and industry standards relating to privacy, data security, and data protection.
• Outcome of legal proceedings relating to business operations, including ongoing litigation.
• Risks related to indebtedness, including changes in interest rates and restrictions in the credit agreement that limit flexibility in operating the business.

Future Outlook

The company plans to open approximately 32 new stores in fiscal year 2025, continuing to monitor future new store openings based on incremental free cash flow generation. Management expects wage rate pressure and raw material price increases to continue. The company anticipates certain provisions of the 'One Big Beautiful Bill Act' (Tax Act) will decrease cash taxes paid in the current fiscal year and may alter the timing of future cash tax payments. Management believes current cash, operational cash flow, and available revolving credit will be sufficient to fund working capital, liquidity, capital expenditures, and debt payments for the next 12 months and the foreseeable future. The company may consider future debt or equity issuances, refinancing, or interest rate derivative agreements to manage liquidity and interest rate exposure. Full cash repayment is anticipated for the investment in an AI entity following its acquisition by a co-preferred investor, with no gain or loss expected.

Management Comments

• "We believe that vision is central to quality of life and that people deserve to see their best to live their best, regardless of their budget."
• "Our mission is to make quality eye care and eyewear affordable and accessible to all Americans."
• "We deliver exceptional value and convenience to our customers, with attractive price points that provide value for a range of consumers."
• "We continue to focus on expanding our target demographic, implementing new pricing architecture, enhancing the customer and patient experience, and optimizing cost structure, which are initiatives designed to strengthen our core business, improve our results of operations, and drive long-term shareholder value."
• "We plan to open approximately 32 new stores in fiscal year 2025 to allow us to invest capital in existing operations to enhance the overall store experience."
• "We are continuing to monitor and determine our plans for future new store openings at a level appropriate for incremental free cash flow generation."
• "We have historically employed a simple low price/high value strategy and seek to balance our pricing and growth in a way that consistently delivers savings to our customers."

Industry Context

The company operates in a highly competitive optical retail industry, facing challenges such as an increasingly tight recruiting market for vision care professionals, leading to constraints in exam capacity and rising employment costs. The broader economic environment remains uncertain, with macroeconomic factors like inflation, trade restrictions (e.g., new universal baseline tariffs and investigations into medical equipment imports), and consumer spending patterns impacting the business. The company's investment in an AI-powered retinal imaging entity reflects a trend towards technological innovation in eye care to enhance screening and diagnostic tools.

Legal Proceedings

• A California wage and hour class action lawsuit was settled for a gross fund of $4.6 million, with final approval granted on July 29, 2025, and payment made on October 10, 2025.
• A Securities Class Action complaint alleging violations of Sections 10(b) and 20(a) of the Exchange Act was dismissed with prejudice on March 30, 2024, and a motion for reconsideration was denied on March 24, 2025, with no appeal filed.
• A Stockholder Derivative Action, based on the same alleged facts as the Securities Class Action, is ongoing, with a motion to dismiss filed on October 31, 2024, and oral argument held on October 28, 2025. The defendants intend to vigorously defend the litigation.
• A post-mediation agreement was reached on October 3, 2025, for the company to pay $1.8 million (net of anticipated recoveries from professional liability insurance) to settle an Alabama state court lawsuit alleging medical negligence.

Related Party Transactions

• The company has consolidated 29 professional corporations as variable interest entities (VIEs) as of September 27, 2025, for which it is the primary beneficiary. Total assets of these VIEs were $6.1 million and liabilities were $5.5 million.

Stakeholder Impact

• Shareholders: Positive impact due to significant return to profitability, strong revenue and comparable store sales growth, improved EPS, and effective debt management. Resolution of some legal matters reduces uncertainty.
• Employees: Severance benefits indicate some organizational restructuring. The challenging recruiting market for vision care professionals may lead to increased competition for talent and potentially higher compensation costs.
• Customers: Continued focus on affordability, accessibility, and enhancing the customer experience through strategic initiatives and pricing architecture is beneficial for value-seeking consumers.
• Suppliers: Inflationary pressures on raw materials and dependence on a limited number of suppliers could impact costs and supply chain stability.
• Creditors: Positive impact from the full repayment of the 2025 Notes and compliance with all debt covenants, demonstrating financial stability and responsible debt management.

Next Steps

• Open approximately 32 new stores in fiscal year 2025.
• Continue to monitor and determine plans for future new store openings at a level appropriate for incremental free cash flow generation.
• Evaluate the impact of new accounting guidance, including ASU 2023-09 (Income Taxes), ASU 2024-03 (Expense Disaggregation Disclosures), ASU 2025-05 (Credit Losses for Accounts Receivable and Contract Assets), and ASU 2025-06 (Intangibles Internal-Use Software).
• Complete payment of $1.8 million for the Alabama medical negligence lawsuit settlement within 30 days of execution of the agreement and dismissal of the lawsuit (agreement reached October 3, 2025).
• Anticipate receiving full cash repayment for the investment in the AI-powered retinal imaging entity following its acquisition by a co-preferred investor.

Key Dates

Recommendation

The company has demonstrated a strong financial rebound, transitioning from a net loss to significant profitability in Q3 2025, accompanied by robust revenue growth and impressive Adjusted Comparable Store Sales Growth. This indicates effective execution of strategic initiatives and strong underlying demand. The reduction in asset impairment charges and successful repayment of convertible notes further strengthen the balance sheet and operational efficiency. While cash on hand decreased, operating cash flow improved, and liquidity remains ample. The resolution of key legal proceedings also removes significant uncertainties. These positive trends suggest a favorable outlook for future performance and shareholder value.

Keywords

Optical Retail, Eyeglasses, Contact Lenses, Vision Care, SEC Filing, 10-Q, Financial Results, Earnings, Revenue Growth, Comparable Store Sales, National Vision Holdings, EYE, Americas Best, Eyeglass World, Managed Care, Debt Repayment, Legal Settlement